EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeting the DNA Damage Response for Cancer Therapy

Ruoxi Wang iD, Yating Sun, Chunshuang Li, Yaoyao Xue iD, Xueqing Ba

International Journal of Molecular Sciences · 02.11.2023 · 24 (21) · 15907

DOI: 10.3390/ijms242115907 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 02.11.2023. Verfasst von Ruoxi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cell Structure and Function, Key Laboratory of Animal Resistance Biology of Shandong Province, College of Life Sciences, Shandong Normal U…. Hauptthemen laut MEDLINE: DNA Repair, Neoplasms. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China postdoctoral Science Foundation Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the course of long-term evolution, cells have developed intricate defense mechanisms in response to DNA damage; these mechanisms play a pivotal role in maintaining genomic stability. Defects in the DNA damage response pathways can give rise to various diseases, including cancer. The DNA damage response (DDR) system is instrumental in safeguarding genomic stability. The accumulation of DNA damage and the weakening of DDR function both promote the initiation and progression of tumors. Simultaneously, they offer opportunities and targets for cancer therapeutics. This article primarily elucidates the DNA damage repair pathways and the progress made in targeting key proteins within these pathways for cancer treatment. Among them, poly (ADP-ribose) polymerase 1 (PARP1) plays a crucial role in DDR, and inhibitors targeting PARP1 have garnered extensive attention in anticancer research. By delving into the realms of DNA damage and repair, we aspire to explore more precise and effective strategies for cancer therapy and to seek novel avenues for intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA RepairNeoplasmsHumansPoly(ADP-ribose) Polymerase InhibitorsDNA DamagePoly (ADP-Ribose) Polymerase-1Genomic Instability

Stichwörter der Autor:innen

DNA damage responseDNA repairPARP1cancer therapydouble-strand DNA break repair

Substanzen

Poly(ADP-ribose) Polymerase InhibitorsPoly (ADP-Ribose) Polymerase-1

Autor:innen und Institutionen

  • Center for Cell Structure and Function, Key Laboratory of Animal Resistance Biology of Shandong Province, College of Life Sciences, Shandong Normal University, Jinan 250014, China.
  • Key Laboratory of Molecular Epigenetics of Ministry of Education, College of Life Sciences, Northeast Normal University, Changchun 130024, China.

ORCID-Profile: Ruoxi Wang, Yaoyao Xue

Förderung

  • National Natural Science Foundation of China
  • China postdoctoral Science Foundation Grant

Zitieren

APA

Wang, R., Sun, Y., Li, C., Xue, Y., & Ba, X. (2023). Targeting the DNA Damage Response for Cancer Therapy. International Journal of Molecular Sciences, 24(21), 15907. https://doi.org/10.3390/ijms242115907

Vancouver

Wang R, Sun Y, Li C, Xue Y, Ba X. Targeting the DNA Damage Response for Cancer Therapy. International Journal of Molecular Sciences. 2023;24(21):15907. doi:10.3390/ijms242115907

BibTeX
@article{Wang2023,
  author = {Wang, Ruoxi and Sun, Yating and Li, Chunshuang and Xue, Yaoyao and Ba, Xueqing},
  title = {Targeting the DNA Damage Response for Cancer Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {21},
  pages = {15907},
  doi = {10.3390/ijms242115907}
}
Kostenlos starten →